Navigation Links
TODAY: Press Call on SCOTUS Bartlett Generic Drug Safety Decision
Date:6/24/2013

WASHINGTON, June 24, 2013 /PRNewswire-USNewswire/ -- The following is being released by the American Association for Justice:

Today the U.S. Supreme Court issued another handout to the generic drug industry, shielding it from lawsuits for the design of their drugs at the cost of consumer safety.  In a 5-4 decision in Mutual Pharmaceutical Co. v. Bartlett the Court, once again, let a generic drug manufacturer off the hook for the safety of the drugs they produce.  

Despite lower court rulings in favor of Karen Bartlett that the drug she took is an unreasonably unsafe drug, SCOTUS sided with Mutual and decided that they cannot be held responsible for the design of their drugs.

WHAT:    Press call on SCOTUS decision in Mutual Pharmaceutical Co. v. Bartlett

WHEN:    TODAY, Monday, June 24, 2013, at 2:30 p.m. EDT

WHO:  
Lou Bograd with the Center for Constitutional Litigation
Allison Zieve with Public Citizen
Sue Steinman with the American Association for Justice
David Fredrick argued this case for Bartlett in front of SCOTUS

CALL-IN #: 1-800-434-1335; Conference Code: 971187#

The Facts

  • Generic drug corporations are off the hook from legal accountability due to the U.S. Supreme Court case Pliva v. Mensing.  [U.S. Supreme Court]
  • Nearly 80 percent of all prescriptions in the U.S. are filled with the generic version of a drug.  [U.S. Food and Drug Administration]
  • Half of all black box warnings on drugs introduced after 1975 were added after the drug had received FDA approval and been on the market for seven years.  [The Journal of American Medical Association]

Mutual Pharmaceutical Co. v. Bartlett (argued March 19, 2013)

  • Karen Bartlett, of Plaistow, N.H, was prescribed a drug for shoulder pain that was filled with generic sulindac. 
  • Soon after, two-thirds of her skin began shedding off and she spent months in a burn unit in a medically induced coma. 
  • She endured 13 eye surgeries and numerous cornea implants. 
  • She now has trouble walking, is legally blind and will need care for the rest of her life due to Stevens-Johnson syndrome which she developed as a result of taking the generic drug.
  • Lower courts concurred sulindac was unreasonably dangerous compared to similar drugs, awarding Karen $21 million in damages for her injuries. 
  • Mutual argued it is only making a copy of the brand drug, and therefore it has no legal responsibility for its design or safety.

AAJ filed comments in support of Public Citizen's citizen petition asking the FDA to address the Mensing decision.  Public Citizen also issued a new report today highlighting how many potential hazards are not discovered until years after drugs have been on the market and the risk this poses to patients.

For more information on generic drugs, please visit www.TakeJusticeBack.com/GenericDrugs.

As the world's largest trial bar, the American Association for Justice (formerly known as the Association of Trial Lawyers of America) works to make sure people have a fair chance to receive justice through the legal system when they are injured by the negligence or misconduct of others--even when it means taking on the most powerful corporations. Visit http://www.justice.org.


'/>"/>
SOURCE American Association for Justice
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
2. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
3. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
4. Marketing Services Groups Face Constant Pressure to Evaluate and Evolve their Organization
5. NeuroSigma Launches Dedicated Website to Introduce Its Monarch eTNS System for Epilepsy and Depression
6. Astute Medical, Inc. patrocinerà il simposio informativo presso il meeting sulla nefrologia in terapia intensiva
7. Pressure BioSciences Announces Core Technology Breakthrough
8. Charlotte Based Compression And Vacuum Therapy Technology Helps Train Cyclist In Race Across America
9. Pressure BioSciences, Inc. to Present at the Marcum MicroCap Conference
10. Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company
11. Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , April 26, 2017 Phoenix Marketing Solutions ( ... year of fulfilling its mission of transforming science into clinical ... scrutinized, Phoenix,s innovative approach supports the ... about the latest advances in science and medicine — which ... was founded in 2002 by Tracy Doyle ...
(Date:4/25/2017)... International plc (NASDAQ: ENDP ) will announce its first-quarter ... team will host a conference call and webcast before the U.S. ... dial-in number to access the call is U.S./ Canada ... Please dial in 10 minutes prior to the scheduled start time. ... will be available from May 9, 2017 at 11:30 a.m. ET ...
(Date:4/24/2017)... UNION CITY, Calif. , April 24, 2017 /PRNewswire/ ... providing durability, grip, protection, and comfort, announces the release ... the Powerform S8+. This most recent example of leading ... high density grip pattern for 200% more tactile grip ... in user protection and durability. With TracTek and a ...
Breaking Medicine Technology:
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Plastic Surgery ... , have been asked to present at the upcoming Aesthetic Meeting. Held in San ... 27-May 2. Drs. Furnas and Canales will lend their expertise to the Premier Global ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs ... of e-prescribing as measured in Part D Medicare data. The dataset, called PaPR ... either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") data set ...
(Date:4/26/2017)... ... , ... Miami native and local periodontist Dr. John Paul Gallardo ... back in 1991 that this journey would have taken me into so many learning ... Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader in ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a ... announce that it has received 510(k) clearance from the U.S. Food & Drug ... MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... 25, 2017 , ... A stressful work environment can hurt the physical and ... and performance in the workplace. The goal of Clearview Resolution Services has always been ... April, Clearview Resolution Services will be shutting down the office early on Fridays. The ...
Breaking Medicine News(10 mins):